Arm A Type of group

A Randomized, Double Blind, Parallel Group, Placebo Controlled Outpatient Study to Examine the Safety, Tolerability and Efficacy of Single Oral Doses of Rizatriptan 10 mg and Zolmitriptan 2.5 mg for the Acute Treatment of Migraine.

Randomised double-blind trial in postmenopausal women wlth primary breast cancer who have received adjuvant tamoxifen for 2-3 years, comparing treatment untll 5 years with adjuvant exemestane versus further tamoxifen

RANDOMIZED STUDY, PHASE IIB WITH A NEW COMBINATION OF AMPHOSTINE MORE CHOP VS. CHOP, IN ELDERLY PATIENTS WITH NON-HODGKIN LYMPHOMA

PHASE III STUDY OF GEMCITABIN WITH PACLITAXEL VERSUS PACLITAXEL IN PATIENTS WITH NON-RESECTIOUS, METASTASIC OR LOCALLY ADVANCED BREAST CANCER

RANDOMIZED STUDY OF COADYUVANT CHEMOTHERAPY WITH STANDARD REGIMES OF CYCLOPHOSPHAMIDE, METHOTREXATE AND FLUORURACILO - (CMF) OR DOXORUBICINE AND CICLOFOSFAMIDA - (AC) VERSUS CAPECITABINE IN WOMEN 65 YEARS OF AGE OR MORE POSITIVE OR NEGATIVE NODULES WITH HIGH-RISK BREAST CANCER.

A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia

OPEN STUDY, MULTICENTER, RANDOMIZED, PHASE 3, OF S-1 IN COMBINATION WITH CISPLATINE COMPARED AGAINST 5-FU IN COMBINATION WITH CISPLATINO, IN PATIENTS WITH ADVANCED GASTRIC CANCER NOT TREATED PREVIOUSLY WITH CHEMOTHERAPY FOR ADVANCED DISEASE

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056)

Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis (STRIDE)

A PHASE II / III STUDY OF TREATMENT WITH MK-0646 IN COMBINATION WITH CETUXIMAB AND IRINOTECAN FOR PATIENTS WITH METASTASIC COLORECTAL CANCER

Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy SUN 1120

Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer

Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology

A PHASE III DOUBLE-BLIND RANDOMISED STUDY ASSESSING THE EFFICACY AND SAFETY OF CAPIVASERTIB + PACLITAXEL VERSUS PLACEBO + PACLITAXEL AS FIRST-LINE TREATMENT FOR PATIENTS WITH HISTOLOGICALLY CONFIRMED, LOCALLY ADVANCED (INOPERABLE) OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER (TNBC) (CAPITELLO-290)

A PHASE III, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE STUDY OF THE EFFICACY AND SAFETY OF ATEZOLIZUMAB PLUS CHEMOTHERAPY FOR PATIENTS WITH EARLY RELAPSING RECURRENT (INOPERABLE LOCALLY ADVANCED OR METASTATIC) TRIPLE-NEGATIVE BREAST CANCER

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, MULTICENTER, GLOBAL STUDY OF MONALIZUMAB OR PLACEBO IN COMBINATION WITH CETUXIMAB IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK PREVIOUSLY TREATED WITH AN IMMUNE CHECKPOINT INHIBITOR